Katell Beauvais

921 total citations
10 papers, 236 citations indexed

About

Katell Beauvais is a scholar working on Neurology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Katell Beauvais has authored 10 papers receiving a total of 236 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Neurology, 4 papers in Cellular and Molecular Neuroscience and 3 papers in Psychiatry and Mental health. Recurrent topics in Katell Beauvais's work include Amyotrophic Lateral Sclerosis Research (3 papers), Epilepsy research and treatment (3 papers) and Genetic Neurodegenerative Diseases (3 papers). Katell Beauvais is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (3 papers), Epilepsy research and treatment (3 papers) and Genetic Neurodegenerative Diseases (3 papers). Katell Beauvais collaborates with scholars based in France and Switzerland. Katell Beauvais's co-authors include A. Furby, Claire De Barace, Véronique Sebille, Philippe Latour, Florence Riant, Elisabeth Tournier‐Lasserve, Marc Tardieu, B. Eymard, Pascale Marcorelles and Anthony Béhin and has published in prestigious journals such as Journal of Neurology Neurosurgery & Psychiatry, Journal of Neurology and Archives of Disease in Childhood Fetal & Neonatal.

In The Last Decade

Katell Beauvais

10 papers receiving 229 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katell Beauvais France 8 116 50 45 38 34 10 236
A. Furby France 10 128 1.1× 49 1.0× 40 0.9× 106 2.8× 76 2.2× 20 361
Gavin McCluskey United Kingdom 11 189 1.6× 32 0.6× 45 1.0× 48 1.3× 16 0.5× 16 291
Dimitri Vanhauwaert Belgium 10 71 0.6× 43 0.9× 15 0.3× 25 0.7× 57 1.7× 27 235
Judith Weisenberg United States 8 63 0.5× 57 1.1× 122 2.7× 66 1.7× 56 1.6× 18 270
Koji Abe Japan 10 114 1.0× 20 0.4× 20 0.4× 121 3.2× 28 0.8× 24 321
Kazutaka Yatsushiro Japan 7 36 0.3× 20 0.4× 20 0.4× 34 0.9× 34 1.0× 18 224
Ervina Bilić Croatia 9 154 1.3× 11 0.2× 33 0.7× 52 1.4× 47 1.4× 37 309
Christine Ioos France 8 48 0.4× 26 0.5× 41 0.9× 69 1.8× 58 1.7× 11 254
Rosario Berardi Italy 14 36 0.3× 108 2.2× 84 1.9× 146 3.8× 47 1.4× 29 422
Debayan Dasgupta United Kingdom 9 60 0.5× 20 0.4× 30 0.7× 25 0.7× 81 2.4× 18 241

Countries citing papers authored by Katell Beauvais

Since Specialization
Citations

This map shows the geographic impact of Katell Beauvais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katell Beauvais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katell Beauvais more than expected).

Fields of papers citing papers by Katell Beauvais

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katell Beauvais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katell Beauvais. The network helps show where Katell Beauvais may publish in the future.

Co-authorship network of co-authors of Katell Beauvais

This figure shows the co-authorship network connecting the top 25 collaborators of Katell Beauvais. A scholar is included among the top collaborators of Katell Beauvais based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katell Beauvais. Katell Beauvais is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Delpont, Benoît, Katell Beauvais, Agnès Jacquin-Piques, et al.. (2018). Clinical features of pain in amyotrophic lateral sclerosis: A clinical challenge. Revue Neurologique. 175(1-2). 11–15. 12 indexed citations
2.
Marin, Benôıt, Géraldine Lautrette, Marie Nicol, et al.. (2017). Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment*. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 18(7-8). 519–527. 14 indexed citations
3.
Beauvais, Katell, et al.. (2011). Prognostic value of EEG in very premature newborns. Archives of Disease in Childhood Fetal & Neonatal. 97(2). F106–F109. 47 indexed citations
4.
Furby, A., Anthony Béhin, Katell Beauvais, et al.. (2009). Late-onset cervicoscapular muscle atrophy and weakness after radiotherapy for Hodgkin disease: a case series. Journal of Neurology Neurosurgery & Psychiatry. 81(1). 101–104. 51 indexed citations
5.
Furby, A., et al.. (2009). Rural environment and risk factors of amyotrophic lateral sclerosis: a case–control study. Journal of Neurology. 257(5). 792–798. 36 indexed citations
7.
Beauvais, Katell, Arnaud Biraben, Éric Seigneuret, Stéphan Saïkali, & Jean‐Marie Scarabin. (2005). Subjective signs in premotor epilepsy: confirmation by stereo‐electroencephalography. Epileptic Disorders. 7(4). 347–354. 10 indexed citations
8.
Beauvais, Katell, Florence Riant, Claire De Barace, et al.. (2004). New CACNA1A Gene Mutation in a Case of Familial Hemiplegic Migraine with Status epilepticus. European Neurology. 52(1). 58–61. 38 indexed citations
9.
Beauvais, Katell, et al.. (2002). Mouvements buccaux complexes critiques explorés en stéréo-EEG. 14(3). 171–176. 2 indexed citations
10.
Beauvais, Katell, Arnaud Biraben, Éric Seigneuret, & Jean‐Marie Scarabin. (2001). Céphalées d'origine épileptique. 13(3). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026